Evidence map›Paper›PMID 30886209›Full record

ArticleScientific reports2019

Targeted Single Primer Enrichment Sequencing with Single End Duplex-UMI.

Quan Peng, Chang Xu, Daniel Kim, Marcus Lewis, John DiCarlo, Yexun Wang

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. SomaticCells · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Quan PengResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA.
Chang XuResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA.ORCID 0000-0003-2737-4312
Daniel KimResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA.
Marcus LewisResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA.
John DiCarloResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA.
Yexun WangResearch and Foundation Department, QIAGEN Sciences, Inc., Frederick, Maryland, USA. yexun.wang@qiagen.com.ORCID 0000-0003-0362-1892

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For specific detection of somatic variants at very low levels, artifacts from the NGS workflow have to be eliminated. Various approaches using unique molecular identifiers (UMI) to analytically remove NGS artifacts have been described. Among them, Duplex-seq was shown to be highly effective, by leveraging the sequence complementarity of two DNA strands. However, all of the published Duplex-seq implementations so far required pair-end sequencing and in the case of combining duplex sequencing with target enrichment, lengthy hybridization enrichment was required. We developed a simple protocol, which enabled the retrieval of duplex UMI in multiplex PCR based enrichment and sequencing. Using this protocol and reference materials, we demonstrated the accurate detection of known SNVs at 0.1-0.2% allele fractions, aided by duplex UMI. We also observed that low level base substitution artifacts could be introduced when preparing in vitro DNA reference materials, which could limit their utility as a benchmarking tool for variant detection at very low levels. Our new targeted sequencing method offers the benefit of using duplex UMI to remove NGS artifacts in a much more simplified workflow than existing targeted duplex sequencing methods.

Indexed as

ArtifactsDNADNA Mutational AnalysisHigh-Throughput Nucleotide SequencingHumansLimit of DetectionMultiplex Polymerase Chain ReactionMutationNeoplasmsPolymorphism, Single NucleotideWorkflowDNA

Identifiers

PMID30886209
PMCPMC6423013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.